Abivax in Podcasts

abivax was this company that was not doing great for a long time on on european public market and then went public on on nasdaq you know still had it was had the had the pressure of this european companies that hasn't yet demonstrated that its product works and look what happens when when you come out with you know phase three results that is absolutely clear-cut and everyone needs to recognize wow this could be a major drug